Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Market Cap	6.02B
Revenue (ttm)	8.47B
Net Income (ttm)	447.97M
Shares Out	107.42M
EPS (ttm)	4.17
PE Ratio	13.43
Forward PE	n/a
Dividend	1.40 (2.48%)
Ex-Dividend Date	n/a

Volume	289,703
Average Volume	839,181
Open	56.50
Previous Close	56.40
Day's Range	55.20 - 57.30
52-Week Range	36.20 - 65.80
Beta	-0.14
RSI	40.26
Earnings Date	Oct 21, 2025

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. The company was incorporated in 1986 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 4,408
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: NAVANAPHAR

Financial Performance

In 2024, Navana Pharmaceuticals's revenue was 6.90 billion, an increase of 20.89% compared to the previous year's 5.71 billion. Earnings were 404.63 million, an increase of 13.36%.